On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease

Nitric Oxide - Biology and Chemistry

Volumn 22, Issue 2, 2010, Pages 155-167

  Saijo, Fumito ^a   Milsom, Alexandra B ^a   Bryan, Nathan S ^a   Bauer, Selena M ^a   Vowinkel, Thorsten ^b   Ivanovic, Marina ^a   Andry, Chris ^a   Granger, D Neil ^b   Rodriguez, Juan ^c   Feelisch, Martin ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c CENTENARY COLLEGE OF LOUISIANA   (United States)

Author keywords

5 Aminosalicylate; Ascorbate; Hypoxia; Inflammation; Inflammatory bowel disease; Nitric oxide; Nitrite; Nitrosation; Redox signaling; Ulcerative colitis

Indexed keywords

ASCORBIC ACID; BIOLOGICAL MARKER; DOCUSATE SODIUM; MESALAZINE; NITRATE; NITRIC OXIDE; NITRITE; NITROSO DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DYNAMICS; ENTERITIS; EXTRAVASCULAR SPACE; HYPOXIA; INFLAMMATION; INTRAVASCULAR SPACE; MALE; NITROSATIVE STRESS; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TISSUE OXYGENATION;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; INFLAMMATORY BOWEL DISEASES; MALE; MESALAMINE; NITRATES; NITRIC OXIDE; NITRITES; RATS; RATS, WISTAR;

RATTUS;

EID: 75149152335     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2009.11.009     Document Type: Article

References (74)

1. Bryan N.S., Rassaf T., Maloney R.E., Rodriguez C.M., Saijo F., Rodriguez J.R., and Feelisch M. Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc. Natl. Acad. Sci. USA 101 (2004) 4308-4313
2. Stuehr D.J., and Griffith O.W. Mammalian nitric oxide synthases. Adv. Enzymol. Relat. Areas Mol. Biol. 65 (1992) 287-346
3. Kolios G., Valatas V., and Ward S.G. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 113 (2004) 427-437
4. Tsikas D., Gutzki F.M., and Stichtenoth D.O. Circulating, excretory nitrite, nitrate as indicators of nitric oxide synthesis in humans methods of analysis. Eur. J. Clin. Pharmacol. 62 Suppl. 13 (2006) 51-59
5. Guevara I., Iwanejko J., Dembinska-Kiec A., Pankiewicz J., Wanat A., Anna P., Golabek I., Bartus S., Malczewska-Malec M., and Szczudlik A. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin. Chim. Acta 274 (1998) 177-188
6. Wang J., Brown M.A., Tam S.H., Chan M.C., and Whitworth J.A. Effects of diet on measurement of nitric oxide metabolites. Clin. Exp. Pharmacol. Physiol. 24 (1997) 418-420
7. Bryan N.S., Fernandez B.O., Bauer S.M., Garcia-Saura M.F., Milsom A.B., Rassaf T., Maloney R.E., Bharti A., Rodriguez J., and Feelisch M. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat. Chem. Biol. 1 (2005) 290-297
8. Lundberg J.O., Weitzberg E., and Gladwin M.T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 7 (2008) N156-N167
9. Butler A.R., and Feelisch M. Therapeutic uses of inorganic nitrite and nitrate: from the past to the future. Circulation 117 (2008) 2151-2159
10. van Faassen E.E., Bahrami S., Feelisch M., Hogg N., Kelm M., Kim-Shapiro D.B., Kozlov A.V., Li H., Lundberg J.O., Mason R., Nohl H., Rassaf T., Samouilov A., Slama-Schwok A., Shiva S., Vanin A.F., Weitzberg E., Zweier J., and Gladwin M.T. Nitrite as regulator of hypoxic signaling in mammalian physiology. Med. Res. Rev. 29 (2009) 683-741
11. Angelo M., Singel D.J., and Stamler J.S. An S-nitrosothiol (SNO) synthase function of hemoglobin that utilizes nitrite as a substrate. Proc. Natl. Acad. Sci. USA 103 (2006) 8366-8371
12. Calvert J.W., and Lefer D.J. Myocardial protection by nitrite. Cardiovasc. Res. 83 2 (2009) 195-203
13. Kleinbongard P., Dejam A., Lauer T., Rassaf T., Schindler A., Picker O., Scheeren T., Godecke A., Schrader J., Schulz R., Heusch G., Schaub G.A., Bryan N.S., Feelisch M., and Kelm M. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic. Biol. Med. 35 (2003) 790-796
14. Andoh A., Yoshida T., Yagi Y., Bamba S., Hata K., Tsujikawa T., Kitoh K., Sasaki M., and Fujiyama Y. Increased aggregation response of platelets in patients with inflammatory bowel disease. J. Gastroenterol. 41 (2006) 47-54
15. Danese S., Motte Cd Cde L., and Fiocchi C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am. J. Gastroenterol. 99 (2004) 938-945
16. Collins C.E., Cahill M.R., Newland A.C., and Rampton D.S. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 106 (1994) 840-845
17. Kapsoritakis A.N., Koukourakis M.I., Sfiridaki A., Potamianos S.P., Kosmadaki M.G., Koutroubakis I.E., and Kouroumalis E.A. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am. J. Gastroenterol. 96 (2001) 776-781
18. Miehsler W., Reinisch W., Valic E., Osterode W., Tillinger W., Feichtenschlager T., Grisar J., Machold K., Scholz S., Vogelsang H., and Novacek G. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?. Gut 53 (2004) 542-548
19. Quera R., and Shanahan F. Thromboembolism - an important manifestation of inflammatory bowel disease. Am. J. Gastroenterol. 99 (2004) 1971-1973
20. Solem C.A., Loftus E.V., Tremaine W.J., and Sandborn W.J. Venous thromboembolism in inflammatory bowel disease. Am. J. Gastroenterol. 99 (2004) 97-101
21. Talbot R.W., Heppell J., Dozois R.R., and Beart Jr. R.W. Vascular complications of inflammatory bowel disease. Mayo Clin. Proc. 61 (1986) 140-145
22. Dijkstra G., Moshage H., van Dullemen H.M., de Jager-Krikken A., Tiebosch A.T., Kleibeuker J.H., Jansen P.L., and van Goor H. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J. Pathol. 186 (1998) 416-421
23. Godkin A.J., De Belder A.J., Villa L., Wong A., Beesley J.E., Kane S.P., and Martin J.F. Expression of nitric oxide synthase in ulcerative colitis. Eur. J. Clin. Invest. 26 (1996) 867-872
24. Herulf M., Ljung T., Hellstrom P.M., Weitzberg E., and Lundberg J.O. Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method. Scand. J. Gastroenterol. 33 (1998) 164-169
25. Ikeda I., Kasajima T., Ishiyama S., Shimojo T., Takeo Y., Nishikawa T., Kameoka S., Hiroe M., and Mitsunaga A. Distribution of inducible nitric oxide synthase in ulcerative colitis. Am. J. Gastroenterol. 92 (1997) 1339-1341
26. Kimura H., Hokari R., Miura S., Shigematsu T., Hirokawa M., Akiba Y., Kurose I., Higuchi H., Fujimori H., Tsuzuki Y., Serizawa H., and Ishii H. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 42 (1998) 180-187
27. Lundberg J.O., Weitzberg E., Lundberg J.M., and Alving K. Intragastric nitric oxide production in humans: measurements in expelled air. Gut 35 (1994) 1543-1546
28. Rachmilewitz D., Stamler J.S., Bachwich D., Karmeli F., Ackerman Z., and Podolsky D.K. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 36 (1995) 718-723
29. Reynolds P.D., Middleton S.J., Hansford G.M., and Hunter J.O. Confirmation of nitric oxide synthesis in active ulcerative colitis by infra-red diode laser spectroscopy. Eur. J. Gastroenterol. Hepatol. 9 (1997) 463-466
30. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E., and Stenson W.F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111 (1996) 871-885
31. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., and Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98 (1990) 694-702
32. Cooper H.S., Murthy S.N., Shah R.S., and Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69 (1993) 238-249
33. Onderdonk A.B., and Bartlett J.G. Bacteriological studies of experimental ulcerative colitis. Am. J. Clin. Nutr. 32 (1979) 258-265
34. Krawisz J.E., Sharon P., and Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87 (1984) 1344-1350
35. Vowinkel T., Kalogeris T.J., Mori M., Krieglstein C.F., and Granger D.N. Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig. Dis. Sci. 49 (2004) 556-564
36. Feelisch M., Rassaf T., Mnaimneh S., Singh N., Bryan N.S., Jourd'Heuil D., and Kelm M. Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo. FASEB J. 16 (2002) 1775-1785
37. Carr R.S., Bally M.B., Thomas P., and Neff J.M. Comparison of methods for determination of ascorbic acid in animal tissues. Anal. Chem. 55 (1983) 1229-1232
38. Terada M., Watanabe Y., Kunitomo M., and Hayashi E. Differential rapid analysis of ascorbic acid and ascorbic acid 2-sulfate by dinitrophenylhydrazine method. Anal. Biochem. 84 (1978) 604-608
39. Kihara N., de la Fuente S.G., Fujino K., Takahashi T., Pappas T.N., and Mantyh C.R. Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats. Gut 52 (2003) 713-719
40. Murthy S., Cooper H.S., Yoshitake H., Meyer C., Meyer C.J., and Murthy N.S. Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis. Aliment. Pharmacol. Ther. 13 (1999) 251-260
41. Stucchi A.F., Shofer S., Leeman S., Materne O., Beer E., McClung J., Shebani K., Moore F., O'Brien M., and Becker J.M. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000) G1298-G1306
42. Ahn B.O., Ko K.H., Oh T.Y., Cho H., Kim W.B., Lee K.J., Cho S.W., and Hahm K.B. Efficacy of use of colonoscopy in dextran sulfate sodium induced ulcerative colitis in rats: the evaluation of the effects of antioxidant by colonoscopy. Int. J. Colorectal. Dis. 16 (2001) 174-181
43. Togawa J., Nagase H., Tanaka K., Inamori M., Nakajima A., Ueno N., Saito T., and Sekihara H. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J. Gastroenterol. Hepatol. 17 (2002) 1291-1298
44. Osman N., Adawi D., Ahrne S., Jeppsson B., and Molin G. Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Dig. Dis. Sci. 49 (2004) 320-327
45. Billiar T.R., and Harbrecht B.G. Resolving the nitric oxide paradox in acute tissue damage. Gastroenterology 113 (1997) 1405-1407
46. Krieglstein C.F., Anthoni C., Cerwinka W.H., Stokes K.Y., Russell J., Grisham M.B., and Granger D.N. Role of blood- and tissue-associated inducible nitric-oxide synthase in colonic inflammation. Am. J. Pathol. 170 (2007) 490-496
47. Rumi G., Tsubouchi R., Nishio H., Kato S., Mózsik G., and Takeuchi K. Dual role of endogenous nitric oxide in development of dextran sodium sulfate-induced colitis in rats. J. Physiol. Pharmacol. 55 (2004) 823-836
48. Aoi Y., Terashima S., Ogura M., Nishio H., Kato S., and Takeuchi K. Roles of nitric oxide (NO) and NO synthases in healing of dextran sulfate sodium-induced rat colitis. J. Physiol. Pharmacol. 59 (2008) 315-336
49. Kimura H., Miura S., Shigematsu T., Ohkubo N., Tsuzuki Y., Kurose I., Higuchi H., Akiba Y., Hokari R., Hirokawa M., Serizawa H., and Ishii H. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig. Dis. Sci. 42 (1997) 1047-1054
50. Guihot G., Guimbaud R., Bertrand V., Narcy-Lambare B., Couturier D., Duee P.H., Chaussade S., and Blachier F. Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease. Amino Acids 18 (2000) 229-237
51. May J.M., Qu Z.C., Xia L., and Cobb C.E. Nitrite uptake and metabolism and oxidant stress in human erythrocytes. Am. J. Physiol. Cell. Physiol. 279 (2000) C1946-C1954
52. Finkel T. Signal transduction by reactive oxygen species in non-phagocytic cells. J. Leukoc. Biol. 65 (1999) 337-340
53. Jourd'heuil D., Jourd'heuil F.L., and Feelisch M. Oxidation and nitrosation of thiols at low micromolar exposure to nitric oxide. Evidence for a free radical mechanism. J. Biol. Chem. 278 (2003) 15720-15726
54. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., and van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391 (1998) 393-397
55. Schopfer F.J., Baker P.R., and Freeman B.A. NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response?. Trends Biochem. Sci. 28 (2003) 646-654
56. Buffinton G.D., and Doe W.F. Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients. Free Radic. Res. 22 (1995) 131-143
57. Nikolaus S., Folscn U., and Schreiber S. Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel disease. Hepatogastroenterology 47 (2000) 71-82
58. Rousseaux C., Lefebvre B., Dubuquoy L., Lefebvre P., Romano O., Auwerx J., Metzger D., Wahli W., Desvergne B., Naccari G.C., Chavatte P., Farce A., Bulois P., Cortot A., Colombel J.F., and Desreumaux P. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J. Exp. Med. 201 (2005) 1205-1215
59. Pearson D.C., Jourd'heuil D., and Meddings J.B. The anti-oxidant properties of 5-aminosalicylic acid. Free Radic. Biol. Med. 21 (1996) 367-373
60. Grisham M.B., and Miles A.M. Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions. Biochem. Pharmacol. 47 (1994) 1897-1902
61. Roediger W.E., Lawson M.J., and Radcliffe B.C. Nitrite from inflammatory cells - a cancer risk factor in ulcerative colitis?. Dis. Colon Rectum 33 (1990) 1034-1036
62. de Kok T.M., Engels L.G., Moonen E.J., and Kleinjans J.C. Inflammatory bowel disease stimulates formation of carcinogenic N-nitroso compounds. Gut 54 (2005) 731
63. M.F. Garcia-Saura, B.O. Fernandez, B.P. McAllister, D.R. Whitlock, W.W. Cruikshank, M. Feelisch, Dermal nitrite application enhances global nitric oxide availability: new therapeutic potential for immunomodulation?,, J. Invest. Dermatol. Oct 8, 2009 (Epub ahead of print).
64. Ostanin D.V., Bao J., Koboziev I., Gray L., Robinson-Jackson S.A., Kosloski-Davidson M., Price V.H., and Grisham M.B. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am. J. Physiol. Gastrointest. Liver Physiol. 296 (2009) G135-G146
65. Cheng Y., and Desreumaux P. 5-Aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease. World J. Gastroenterol. 11 (2005) 309-314
66. Velayos F.S., Terdiman J.P., and Walsh J.M. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am. J. Gastroenterol. 100 (2005) 1345-1353
67. Danese S., Semeraro S., Papa A., Roberto I., Scaldaferri F., Fedeli G., Gasbarrini G., and Gasbarrini A. Extraintestinal manifestations in inflammatory bowel disease. World J. Gastroenterol. 11 (2005) 7227-7236
68. Taylor C.T., and Colgan S.P. Hypoxia and gastrointestinal disease. J. Mol. Med. 85 (2007) 1295-1300
69. Brüne B., and Zhou J. Nitric oxide and superoxide: interference with hypoxic signaling. Cardiovasc. Res. 75 (2007) 275-282
70. Guzy R.D., and Schumacker P.T. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp. Physiol. 91 (2006) 807-819
71. C.T. Taylor, S. Moncada, Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia., Arterioscler. Thromb. Vasc. Biol. Aug 27, 2009 (Epub ahead of print).
72. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., Nizet V., Johnson R.S., Haddad G.G., and Karin M. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453 (2008) 807-811
73. Taniguchi E., Matsunami M., Kimura T., Yonezawa D., Ishiki T., Sekiguchi F., Nishikawa H., Maeda Y., Ishikura H., and Kawabata A. Rhodanese, but not cystathionine-gamma-lyase, is associated with dextran sulfate sodium-evoked colitis in mice: a sign of impaired colonic sulfide detoxification?. Toxicology 264 (2009) 96-103
74. Whiteman M., and Moore P.K. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability?. J. Cell. Mol. Med. 13 (2009) 488-507